Abellanosa, Maychel .

HRN: 29-41-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/06/2026
08/09/2026
IVT
300mg
Q8
Chronic Mastitis
Remove - Pending Acceptance
08/08/2026
CEFAZOLIN 1GM (VIAL)
08/08/2026
08/08/2026
IV
2g
PTOR
STAT CS
Remove - Pending Acceptance
08/08/2026
CEFAZOLIN 1GM (VIAL)
08/08/2026
08/11/2026
IV
1gm
Q8h
S/P CS
Remove - Pending Acceptance
08/10/2026
CEFUROXIME 500MG (TAB)
08/10/2026
08/17/2026
PO
500
Bid
Ltcs
Checking Initial Appropriateness 
08/10/2026
AZITHROMYCIN 500MG TABLET (TAB)
08/10/2026
08/17/2026
PO
500
Od
Cap LR
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: